Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and against adenovirus keratoconjunctivitis in a rabbit model

BACKGROUND: Adenovirus (Ad), associated with significant morbidity, has no topical treatment. A leading CTC compound (CTC-96), a Co(III )chelate, was found to have potent in vitro and in vivo antiviral efficacy against herpes viruses. In this study CTC-96 is being tested for possible anti-Adenovirus activity. METHODS: The biological anti-adenovirus activity of CTC-96 in concentrations from 5 to 250 ug/ml, was evaluated initially by viral inactivation (viral exposure to CTC-96 followed by dilution and inoculation of cells), virucidal (viral exposure to CTC-96 and inoculation of cells without dilution) and antiviral (effect of CTC-96 on previously adsorbed virus) plaque assays on HeLa (human cervical carcinoma), A549 (human lung carcinoma) and SIRC (rabbit corneal) cells. After verifying the antiviral activity, New Zealand White rabbits were infected with Ad-5 into: 1) the anterior cul-de-sac scarifying the conjunctiva (Group "C+"); 2) the anterior cul-de-sac scarifying the conjunctiva and cornea (Group "CC+"); 3) the stroma (Group "CI+"). Controls were sham-infected ("C-", "CC-", "CI-"). Other rabbits, after "CC", were treated for 21 days with: 1) placebo, 9x/day ("-"); 2) CTC-96, 50 ug/ml, 9x/day ("50/9"); CTC-96, 50 ug/ml, 6x/day ("50/6"); CTC-96, 25 ug/ml, 6x/day ("25/6"). All animals were monitored via examination and plaque assays. RESULTS: In vitro viral inactivation, virucidal and antiviral assays all demonstrated CTC-96 to be effective against Adenvirus type 5 (ad-5). The in vivo model of Ad keratoconjunctivitis most similar to human disease and producing highest viral yield was "CC". All eyes (6/6) developed acute conjunctivitis. "CI" yielded more stromal involvement (1/6) and iritis (5/6), but lower clinical scores (area × severity). Infection via "C" was inconsistent (4/6). Fifty (50) ug/ml was effective against Ad-5 at 6x, 9x dosings while 25 ug/ml (6x) was only marginally effective. CONCLUSION: CTC-96 demonstrated virucidal activity against Ad5 in tissue culture with HeLa, A549 and SIRC cell lines. Animal Model Development: 1) "CC" produced conjunctival infection with occasional keratitis similar to human disease; "CI" yielded primarily stromal involvement; 2) "C" consistently produced neither conjunctivitis nor keratitis. CTC Testing: 1) Conjunctivitis in all eyes; 2) Resolution fastest in "50/9" ("50/9". "50/6" > "25/6" > "-"); 3) Efficacy in "50/6" was not statistically different than "50/9"; 4) Conjunctival severity was lower in treatment groups then controls; 5) Little corneal or intra-ocular changes were noted

Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial

Introduction: Patients with atopic dermatitis (AD) have a greater risk of conjunctivitis and other ocular surface disorders than the general population. We evaluated the burden of ocular surface disorders and related symptoms prior to treatment initiation in adults with moderate-tosevere AD. Methods: Patients were enrolled in a randomized, placebo-controlled, double-blinded, phase 3 trial of dupilumab administered with concomitant topical corticosteroids. At the beginning of the screening period, all enrolled patients completed a survey of ocular disorder diagnoses received in the past year; at baseline, patients completed a survey of frequency and severity of ocular symptoms (discomfort, itching, redness, and tearing) experienced in the past month. Results: A total of 712 of 740 patients enrolled in the trial provided responses to the survey. At screening, 286 of 740 patients (38.6%) reported having at least one ocular disorder in the past year. At baseline, 499 of 712 respondents (70.1%) reported having at least one symptom within the past month. Of these patients, 4.4%, 6.0%, 5.5%, and 4.4%, respectively, reported h

A study of family mediation during divorce in the Pakistani Muslim community in Bradford. Some observations on the implications for the theory and practice of conflict resolution.

Conflict resolution theory and practice have been increasingly criticised for ignoring the centrality of culture in their attempts to find theories and models that are applicable universally, not only across cultures but also across levels of society. Mediation is one form of conflict resolution, which has come to occupy a central position in the resolution of disputes both at international and local levels. At the level of family disputes, family mediation has failed to engage users from different ethnic groups in England and Wales. This thesis explores the hypothesis that culture and, in particular, culturally defined concepts of gender are the important factors determining the success or failure of mediation in divorce disputes.J. A. Clark Charitable Trus

Connexin Mediated Cataract Prevention in Mice

Cataracts, named for any opacity in the ocular lens, remain the leading cause of vision loss in the world. Non-surgical methods for cataract prevention are still elusive. We have genetically tested whether enhanced lens gap junction communication, provided by increased α3 connexin (Cx46) proteins expressed from α8(Kiα3) knock-in alleles in Gja8tm1(Gja3)Tww mice, could prevent nuclear cataracts caused by the γB-crystallin S11R mutation in CrygbS11R/S11R mice. Remarkably, homozygous knock-in α8(Kiα3/Kiα3) mice fully prevented nuclear cataracts, while single knock-in α8(Kiα3/−) allele mice showed variable suppression of nuclear opacities in CrygbS11R/S11R mutant mice. Cataract prevention was correlated with the suppression of many pathological processes, including crystallin degradation and fiber cell degeneration, as well as preservation of normal calcium levels and stable actin filaments in the lens. This work demonstrates that enhanced intercellular gap junction communication can effectively prevent or delay nuclear cataract formation and suggests that small metabolites transported through gap junction channels protect the stability of crystallin proteins and the cytoskeletal structures in the lens core. Thus, the use of an array of small molecules to promote lens homeostasis may become a feasible non-surgical approach for nuclear cataract prevention in the future

Ring electrode for radio-frequency heating of the cornea: modelling and in vitro experiments

[EN] Radio-frequency thermokeratoplasty (RF-TKP) is a technique used to reshape the cornea curvature by means of thermal lesions using radio-frequency currents. This curvature change allows refractive disorders such as hyperopia to be corrected. A new electrode with ring geometry is proposed for RF-TKP. It was designed to create a single thermal lesion with a full-circle shape. Finite element models were developed, and the temperature distributions in the cornea were analysed for different ring electrode characteristics. The computer results indicated that the maximum temperature in the cornea was located in the vicinity of the ring electrode outer perimeter, and that the lesions had a semi-torus shape. The results also indicated that the electrode thickness, electrode radius and electrode thermal conductivity had a significant influence on the temperature distributions. In addition, in vitro experiments were performed on rabbit eyes. At 5 IN power the lesions were fully circular. Some lesions showed non-uniform characteristics along their circular path. Lesion depth depended on heating duration (60% of corneal thickness for 20s, and 30% for 10s). The results suggest that the critical shrinkage temperature (55-63degreesC) was reached at the central stroma and along the entire circular path in all the cases.Berjano, E.; Saiz Rodríguez, FJ.; Alió, J.; Ferrero, JM. (2003). Ring electrode for radio-frequency heating of the cornea: modelling and in vitro experiments. Medical & Biological Engineering & Computing. 41(6):630-639. https://doi.org/10.1007/BF02349970S630639416Alió, J. L., Ismail, M. M., Artola, A., andPérez-Santonja, J. J. (1997a): ‘Correction of hyperopia induced by photorefractive keratectomy using non-contact Ho: YAG laser thermal keratoplasty’,J. Refract. Surg.,13, pp. 13–16Alió, J. L., Ismail, M. M., andSanchez, J. L. (1997b): ‘Correction of hyperopia with non-contact Ho: YAG laser thermal keratoplasty’,J. Refract. Surg.,13, pp. 17–22Alió, J. L., andPérez-Santonja, J. J. (1999): ‘Correction of hyperopia by laser thermokeratoplasty (LTK)’ inPallikaris, I., andAgarwal, S. (Eds): ‘Refractive Surgery’ (Jaypee Brothers Medical Publishers Ltd, New Delhi, 1999), pp. 583–591Alió, J. L., andPérez-Santonja, J. J. (2002): ‘Correction of hyperopia by laser thermokeratoplasty (LTK)’ inAgarwal, S., Agarwal, A., Apple, D. J., Buratto, L., Alió, J. L., Pandey, S. K., andAgarwal, A. (Eds): ‘Textbook of ophthalmology’ (Lippincott Williams & Wilkins, Philadelphia, 2002), pp. 1331–1337Ayala, M. J., Alió, J. L., Ismail, M. M., andSánchez-Castro, J. M. (2000): ‘Experimental corneal histological study after thermokeratoplasty with holmium laser’,Arch. Soc. Esp. Oftalmol.,75, pp. 619–626Asbell, P. A., Maloney, R. K., Davidorf, J., Hersh, P., McDonald, M., Manche, E., andConductive Keratoplasty Study Group (2001): ‘Conductive keratoplasty for the correction of hyperopia’,Tr. Am. Ophtalmol. Soc.,99, pp. 79–87Avitall, B., Mughal, K., Hare, J., Helms, R., andKrum, D. (1997): ‘The effects of electrode-tissue contact on radiofrequency lesion generation’PACE,20, pp. 2899–2910Avitall, B., Helms, R. W., Koblish, J. B., Sieben, W., Kotov, A. V., andGupta, G. N. (1999): ‘The creation of linear contiguous lesions in the atria with an expandable loop catheter’,J. Am. Coll. Cardiol.,33, pp. 972–984Berjano, E. J., Saiz, J., andFerrero, J. M. (2002): ‘Radio-frequency heating of the cornea: Theoretical model andin vitro experiments’,IEEE Trans. Biomed. Eng.,49, pp. 196–205Brickmann, R., Kampmeier, J., Grotehusmann, U., Vogel, A., Koop, N., Asiyo-Vogel, M., Kamm, K., andBirngruber, R. (1996): ‘Corneal collagen denaturation in laserthermokeratoplasty’,SPIE Proc.,2681, pp. 56–63Choi, B., Kim, J., Welch, A. J., andPearce, J. A. (2002): ‘Dynamic impedance measurements during radio-frequency heating of cornea’,IEEE Trans. Biomed. Eng.,49, pp. 1610–1616Curley, M. G., andHamilton, P. S. (1997): ‘Creation of large thermal lesions in liver using saline-enhanced RF ablation’. Proc. 19th Ann. Int. Conf. IEEE Eng. Med. Biol. Soc., Chicago, pp. 2516–2519Doss, J. D., andAlbillar, J. I. (1980): ‘A technique for the selective heating of corneal stroma’,Contact Intraocular Lens Med.,6, pp. 13–17Doss, J. D. (1982): ‘Calculation of electric fields in conductive media’,Med. Phys.,9(4), pp. 566–573Gruenberg, P., Manning, W., Miller, D. andOlson, W. (1981): ‘Increase in rabbit corneal curvature by heated ring application’,Ann. Ophthalmol.,13, pp. 67–70Hata, C., andRaymond Chia, W.-K. (2001): ‘Catheter for circular tissue ablation and methods thereof’. US Patent 2001/0044625 A1Jain, M. K., andWolf, P. D. (1998): ‘Effect of electrode contact on lesion growth during temperature controlled radiofrequency ablation’, Proc. 20th Ann. Int. Conf. IEEE Eng. Med. Biol. Soc. Hong Kong (IEEE, Piscataway NJ) pp. 245–247Jain, M. K., andWolf, P. D. (1999): ‘Temperature controlled and constant power radiofrequency ablation: what affects lesion growth?’,IEEE Trans. Biomed. Eng.,46, pp. 1405–1412Krasteva, V. Tz., andPapazov, S. P. (2002): ‘Estimation of current density distribution under electrodes for external defibrillation’,Biomed. Eng. OnLine,1, 7Labonté, S. (1992): ‘A theoretical study of radio-frequency ablation of the myocardium’,PhD dissertation, Department of Electrical Engineering, University of Ottawa, CanadaLabonté, S. (1994): ‘Numerical model for radio-frequency ablation of the endocardium and its experimental validation’,IEEE Trans. Biomed. Eng.,41, pp. 108–115Mannis, M. J., Segal, W. A., andDarlington, J. K. (2001): ‘Making sense of refractive surgery in 2001: Why, when, for whom, and by whom?’,Mayo Clin. Proc.,76, pp. 823–829McCally, R. L., Bargeron, R. A., andGreen, W. R. (1983): ‘Stromal damage in rabbit corneas exposed to CO2 laser radiation’,Exp. Eye Res.,37, pp. 543–550McDonald, M. B., Hersh, P. S., Manche, E. E., Maloney, R. K., Davidorf, J., andSabry, M. (2002): ‘Conductive keratoplasty for the correction of low to moderate hyperopia: U.S. clinical trial 1-year results on 355 eyes’,Ophthalmol.,109, pp. 1978–1989McRury, I. D., Mitchell, M. A., Panescu, D. andHaines, D. E. (1997): ‘Non-uniform heating during radiofrequency ablation with long electrodes: monitoring the edge effect’,Circ.,96, pp. 4057–4064Méndez-g, A., andMéndez-Noble, A. (1997): ‘Conductive keratoplasty of the correction of hyperopia’ inSher, N. A. (Ed.) ‘Surgery for hyperopia and presbyopia’ (Williams & Wilkins, Baltimore, 1997), pp. 163–171Miller, D., andManning, W.J. (1978): ‘Alterations in curvature of bovine cornea using heated rings’,Invest. Ophthalmol., p. 297Mirotznik, M. S., andSchwartzman, D. (1996): ‘Nonuniform heating patterns of commercial electrodes for radiofrequency catheter ablation’,J. Cardiovasc. Electrophysiol.,7, pp. 1058–1062Nakagawa, H., Yamanashi, W. S., Pitha, J. V., Arruda, M., Wang, X., Ohtomo, K., Beckman, K. J., McClelland, J. H., Lazzara, R., andJackman, W. M. (1995): ‘Comparison ofin vivo tissue temperature profile and lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature control in a canine thigh muscle preparation’,Circ.,91, pp. 2264–2273Panescu, D., Whayne, J. G., Fleischman, S. D., Mirotznik, M. S., Swanson, D. K., andWebster, J. G. (1995): ‘Three-dimensional finite element analysis of current density and temperature distributions during radio-frequency ablation’,IEEE Trans. Biomed. Eng.,42, pp. 879–890Plonsey, R., andHeppner, D. B. (1967): ‘Considerations of quasistationarity in electrophysiological systems’,Bull. Math. Biophys.,29, pp. 657–664Rowsey, J. J. (1987): ‘Electrosurgical keratoplasty: Update and retraction’,Invest. Ophthalmol. Vis. Sci.,28, p. 224Rutzen, A. R., Roberts, C. W., Driller, J., Gomez, D., Lucas, B. C., Lizzi, F. L., andColeman, D. J. (1990): ‘Production of corneal lesions using high-intensity focused ultrasound’,Cornea,9, pp. 324–330Schwan, H. P., andFoster, K. R. (1980): ‘RF-fields interactions with biological systems: electrical properties and biophysical mechanism’,Proc. IEEE,68, pp. 104–113Seiler, T., Matallana, M., andBende, T. (1990): ‘Laser thermokeratoplasty by means of a pulsed Holmium:YAG Laser for the hyperopic correction’,Refrac. Corneal Surg.,6, pp. 335–339Silvestrini, T. A. (1998): ‘Electrosurgical procedure for the treatment of the cornea’. US Patent 5,766,171Simmons, W. N., Mackey, S., He, D. S. andMarcus, F. L. (1996): ‘Comparison of gold versus platinum electrodes on myocardial lesion size using radiofrequency energy’,PACE,19, pp. 398–402Stringer, H., andParr, J. (1964): ‘Shrinkage temperature of eye collagen’,Nature,204, p. 1307Trembly, B. S., andKeates, R. H. (1991): ‘Combined microwave heating and surface cooling of the cornea’,IEEE Trans. Biomed. Eng.,38, pp. 85–91Trembly, B. S., Hashizume, N., Moodie, K. L., Cohen, K. L., Tripoli, N. K., andHoopes, P. J. (2001): ‘Microwave thermal keratoplasty for myopia: keratoscopic evaluation in porcine eyes’,J. Refract. Surg.,17, pp. 682–688Tungjitkusolmun, S., Woo, E. J., Cao, H., Tsai, J. Z., Vorperian, V. R., andWebster, J. G. (2000): ‘Thermal-electrical finite element modelling for radio frequency cardiac ablation: effects of changes in myocardial properties’,Med. Biol. Eng. Comput.,38, pp. 562–568Wiley, J. D., andWebster, J. G. (1982): ‘Analysis and control of the current distribution under circular dispersive electrodes’,IEEE Trans. Biomed. Eng,29, pp. 381–38

Specific detection of fungal pathogens by 18S rRNA gene PCR in microbial keratitis

<p>Abstract</p> <p>Background</p> <p>The sensitivity and specificity of 18S rRNA polymerase chain reaction (PCR) in the detection of fungal aetiology of microbial keratitis was determined in thirty patients with clinical diagnosis of microbial keratitis.</p> <p>Methods</p> <p>Corneal scrapings from patients were used for Gram stain, culture and PCR analysis. PCR was performed with primer pairs targeted to the 18S rRNA gene. The result of the PCR was compared with conventional culture and Gram staining method. The PCR positive samples were identified by DNA sequencing of the internal transcribed spacer (ITS) region of the rRNA gene. Main outcome measures were sensitivity and specificity of PCR in the detection of fungus in corneal keratitis.</p> <p>Results</p> <p>Combination of microscopy and culture gave a positive result in 11 of 30 samples of microbial keratitis. PCR detected 10 of 11 samples that were positive by conventional method. One of the 19 samples that was negative by conventional method was positive by PCR. Statistical analysis revealed that the PCR to have a sensitivity of 90.9% and specificity of 94.7% in the detection of a fungal aetiology in microbial keratitis.</p> <p>Conclusion</p> <p>PCR is a rapid, sensitive and useful method to detect fungal aetiology in microbial keratitis.</p

Método automático de clasificación de color en dientes humanos usando aprendizaje de máquina

Trabajo de InvestigaciónActualmente el proceso de identificación del color de los dientes para la fabricación de prótesis dentales es realizado manualmente por un experto que, utilizando un método de identificación visual, determina el color de las piezas dentales en la boca del paciente, usando guías de color como la VITA®. A pesar de que el método visual es el más utilizado para la identificación del color de dientes, este se ve afectado por distintas variables tales como: el cansancio del experto, la luminosidad en el ambiente, salud visual del especialista, entre otras que influyen en la identificación del color en los dientes. Los errores en la clasificación del color de los dientes pueden generar pérdidas de tiempo lo que implicaría en consecuencia sobrecostos que afectarían directamente al fabricante y la satisfacción final del cliente.1. Planteamiento del problema 2. Pregunta de investigación 3. Objetivos 4. Estado del arte 5. Marco de referencia 6. Alcances y limitaciones 7. Metodología 8. Diseño metodológico 9. Discusión y resultados 10. Conclusiones 11. Trabajos futuros 12. Bibliografía 13. ANEXOSPregradoIngeniero de Sistema

Conjunctivitis in dupilumab clinical trials

Background Dupilumab blocks the shared receptor component for interleukin (IL)-4 and IL-13. It is approved in the U.S.A. for patients aged ≥ 12 years with moderate-tosevere atopic dermatitis (AD) uncontrolled by topical prescription medicines or who cannot use topical medicines, for patients in Japan whose AD is uncontrolled with existing therapies, for patients with moderate-to-severe AD in Europe who are candidates for systemic therapy and for patients aged ≥ 12 years for maintenance treatment of moderate-to-severe asthma uncontrolled with their current medicines. AD trials have reported increased incidence of conjunctivitis for dupilumab vs. placebo. Objectives To characterize further the occurrence and risk factors of conjunctivitis in dupilumab clinical trials. Methods We evaluated randomized placebo-controlled trials of dupilumab in AD (n = 2629), asthma (n = 2876), chronic rhinosinusitis with nasal polyps (CRSwNP) (n = 60) and eosinophilic oesophagitis (EoE) (n = 47). Results In most AD trials, dupilumab-treated patients had higher conjunctivitis incidence than placebo controls. Higher baseline AD severity and previous history of conjunctivitis were associated with increased conjunctivitis incidence. Conjunctivitis was mostly mild to moderate. Most cases recovered or resolved during the treatment period; two patients permanently discontinued dupilumab due to conjunctivitis or keratitis. Common treatments included ophthalmic corticosteroids, antibiotics, and antihistamines or mast cell stabilizers. Most cases were diagnosed by the investigators. In asthma and CRSwNP trials, the incidence of conjunctivitis was lower for both dupilumab and placebo than in AD trials; dupilumab did not increase the incidence compared with placebo. In the EoE trial, no patients had conjunctivitis. Conclusions Conjunctivitis was more frequent with dupilumab treatment in most AD trials. In dupilumab trials in other type 2 diseases, incidence of conjunctivitis was overall very low, and was similar for dupilumab and placebo. In AD, the incidence of conjunctivitis was associated with AD severity and prior history of conjunctivitis. The aetiology and treatment of conjunctivitis in dupilumab-treated patients require further study